Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avant Brands Inc T.AVNT

Alternate Symbol(s):  AVTBF

Avant Brands Inc. is a Canada-based cannabis company. The Company produces handcrafted cannabis products. Its products are distributed via three sales channels: recreational, medical and export. The Company's recreational brand portfolio includes BLK MKT, Tenzo, Cognoscente, and Treehugger, which are produced from cultivars, and sold in British Columbia, Saskatchewan, Manitoba, Ontario, Atlantic Canada and the territories. The Company's medical cannabis brand, GreenTec, which is distributed nationwide, directly to patients through its GreenTec Medical portal, and through various medical cannabis partners. The Company has various licensed and operational production facilities across Canada, which produce its consumer brands sold across medical and recreational channels in Canada. Its subsidiaries include Avant Craft Cannabis Inc., GreenTec Bio-Pharmaceuticals Inc., GreenTec Retail Ventures Inc., Grey Bruce Farms Incorporated, Tumbleweed Farms Corp. and Spectre Labs Inc., among others.


TSX:AVNT - Post by User

Post by satchmo6on Apr 12, 2023 2:44pm
202 Views
Post# 35391283

big buyout pending

big buyout pendinghe Financial Post reports in its Wednesday, April 12, edition that Hexo shares tumbled on Tuesday after Tilray Brands announced plans to buy company in an all-share deal worth about $56-million, with an offer price less than the stock's market value prior to the announcement (all figures U.S.). A Bloomberg dispatch to the Post reports that Tilray's implied purchase price in its so-called take-under deal is $1.25 per share, less than Hexo's Monday closing price of $1.64. On Tuesday, Hexo plunged as much as 28 per cent to $1.18 -- paring Monday's 30 per cent rally, which was triggered by a media report implying that Tilray would buy the company for $75-million. Jefferies analyst Owen Bennett said in a note, "The deal is at a discount and with room for material upside on value creation." Tilray had previously bought $173-million in Hexo's debt at a discount, which analysts had said could push the two companies together. Hexo once had a joint venture with Molson Coors to produce CBD drinks, but the companies parted ways. It also announced a deal last September to produce products for Tyson 2.0, a cannabis company co-founded by Mike Tyson.
<< Previous
Bullboard Posts
Next >>